USE OF HUMAN NLK GENE AND ASSOCIATED DRUGS THEREOF
The present invention discloses the use of a human NLK gene and associated drugs thereof. The present invention discloses the use of the NLK gene for tumor treatment, tumor diagnosis and drug preparation. The present invention further constructs an isolated molecule that attenuates expression of the...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | XIE SHENGHUA ZHU XIANGYING SUN QIN GU XUEFENG HAN HAIXIONG LI YANG JIN YANGSHENG QU HONGHUA CAO YUEQIONG |
| description | The present invention discloses the use of a human NLK gene and associated drugs thereof. The present invention discloses the use of the NLK gene for tumor treatment, tumor diagnosis and drug preparation. The present invention further constructs an isolated molecule that attenuates expression of the NLK gene of tumor cells, cells comprising the isolated molecule and a NLK interference lentivirus, and discloses the use thereof as well. The isolated molecule or the NLK interference lentivirus that attenuates expression of the NLK gene provided in the present invention can specifically attenuate expression of the human NLK gene, especially the lentivirus, can effectively infect target cells, efficiently inhibit the expression of the NLK gene in target cells, and inhibit the growth of tumor cells, thus has great significance in tumor treatment. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2015005370A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2015005370A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2015005370A13</originalsourceid><addsrcrecordid>eNrjZDAKDXZV8HdT8Aj1dfRT8PPxVnB39XNVcPRzUXAMDvZ39nQMcXVRcAkKdQ9WCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhqYGBqbG5gaOhsbEqQIA2acnPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF HUMAN NLK GENE AND ASSOCIATED DRUGS THEREOF</title><source>esp@cenet</source><creator>XIE SHENGHUA ; ZHU XIANGYING ; SUN QIN ; GU XUEFENG ; HAN HAIXIONG ; LI YANG ; JIN YANGSHENG ; QU HONGHUA ; CAO YUEQIONG</creator><creatorcontrib>XIE SHENGHUA ; ZHU XIANGYING ; SUN QIN ; GU XUEFENG ; HAN HAIXIONG ; LI YANG ; JIN YANGSHENG ; QU HONGHUA ; CAO YUEQIONG</creatorcontrib><description>The present invention discloses the use of a human NLK gene and associated drugs thereof. The present invention discloses the use of the NLK gene for tumor treatment, tumor diagnosis and drug preparation. The present invention further constructs an isolated molecule that attenuates expression of the NLK gene of tumor cells, cells comprising the isolated molecule and a NLK interference lentivirus, and discloses the use thereof as well. The isolated molecule or the NLK interference lentivirus that attenuates expression of the NLK gene provided in the present invention can specifically attenuate expression of the human NLK gene, especially the lentivirus, can effectively infect target cells, efficiently inhibit the expression of the NLK gene in target cells, and inhibit the growth of tumor cells, thus has great significance in tumor treatment.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150101&DB=EPODOC&CC=US&NR=2015005370A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150101&DB=EPODOC&CC=US&NR=2015005370A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XIE SHENGHUA</creatorcontrib><creatorcontrib>ZHU XIANGYING</creatorcontrib><creatorcontrib>SUN QIN</creatorcontrib><creatorcontrib>GU XUEFENG</creatorcontrib><creatorcontrib>HAN HAIXIONG</creatorcontrib><creatorcontrib>LI YANG</creatorcontrib><creatorcontrib>JIN YANGSHENG</creatorcontrib><creatorcontrib>QU HONGHUA</creatorcontrib><creatorcontrib>CAO YUEQIONG</creatorcontrib><title>USE OF HUMAN NLK GENE AND ASSOCIATED DRUGS THEREOF</title><description>The present invention discloses the use of a human NLK gene and associated drugs thereof. The present invention discloses the use of the NLK gene for tumor treatment, tumor diagnosis and drug preparation. The present invention further constructs an isolated molecule that attenuates expression of the NLK gene of tumor cells, cells comprising the isolated molecule and a NLK interference lentivirus, and discloses the use thereof as well. The isolated molecule or the NLK interference lentivirus that attenuates expression of the NLK gene provided in the present invention can specifically attenuate expression of the human NLK gene, especially the lentivirus, can effectively infect target cells, efficiently inhibit the expression of the NLK gene in target cells, and inhibit the growth of tumor cells, thus has great significance in tumor treatment.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKDXZV8HdT8Aj1dfRT8PPxVnB39XNVcPRzUXAMDvZ39nQMcXVRcAkKdQ9WCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhqYGBqbG5gaOhsbEqQIA2acnPw</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>XIE SHENGHUA</creator><creator>ZHU XIANGYING</creator><creator>SUN QIN</creator><creator>GU XUEFENG</creator><creator>HAN HAIXIONG</creator><creator>LI YANG</creator><creator>JIN YANGSHENG</creator><creator>QU HONGHUA</creator><creator>CAO YUEQIONG</creator><scope>EVB</scope></search><sort><creationdate>20150101</creationdate><title>USE OF HUMAN NLK GENE AND ASSOCIATED DRUGS THEREOF</title><author>XIE SHENGHUA ; ZHU XIANGYING ; SUN QIN ; GU XUEFENG ; HAN HAIXIONG ; LI YANG ; JIN YANGSHENG ; QU HONGHUA ; CAO YUEQIONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2015005370A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>XIE SHENGHUA</creatorcontrib><creatorcontrib>ZHU XIANGYING</creatorcontrib><creatorcontrib>SUN QIN</creatorcontrib><creatorcontrib>GU XUEFENG</creatorcontrib><creatorcontrib>HAN HAIXIONG</creatorcontrib><creatorcontrib>LI YANG</creatorcontrib><creatorcontrib>JIN YANGSHENG</creatorcontrib><creatorcontrib>QU HONGHUA</creatorcontrib><creatorcontrib>CAO YUEQIONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XIE SHENGHUA</au><au>ZHU XIANGYING</au><au>SUN QIN</au><au>GU XUEFENG</au><au>HAN HAIXIONG</au><au>LI YANG</au><au>JIN YANGSHENG</au><au>QU HONGHUA</au><au>CAO YUEQIONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF HUMAN NLK GENE AND ASSOCIATED DRUGS THEREOF</title><date>2015-01-01</date><risdate>2015</risdate><abstract>The present invention discloses the use of a human NLK gene and associated drugs thereof. The present invention discloses the use of the NLK gene for tumor treatment, tumor diagnosis and drug preparation. The present invention further constructs an isolated molecule that attenuates expression of the NLK gene of tumor cells, cells comprising the isolated molecule and a NLK interference lentivirus, and discloses the use thereof as well. The isolated molecule or the NLK interference lentivirus that attenuates expression of the NLK gene provided in the present invention can specifically attenuate expression of the human NLK gene, especially the lentivirus, can effectively infect target cells, efficiently inhibit the expression of the NLK gene in target cells, and inhibit the growth of tumor cells, thus has great significance in tumor treatment.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2015005370A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | USE OF HUMAN NLK GENE AND ASSOCIATED DRUGS THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T19%3A52%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XIE%20SHENGHUA&rft.date=2015-01-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2015005370A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |